Biomarkers and epidemiology
101 – 110 of 138
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Added value of contrast-enhanced mammography (CEM) in staging of malignant breast lesions - A feasibility study
(
- Contribution to journal › Article
-
Mark
Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk
(
- Contribution to journal › Article
-
Mark
Linear age-course effects on the associations between body mass index, triglycerides, and female breast and male liver cancer risk : An internal replication study of 800,000 individuals
(
- Contribution to journal › Article
-
Mark
Comprehensive transcriptomic profiling identifies breast cancer patients who may be spared adjuvant systemic therapy
(
- Contribution to journal › Article
-
Mark
Desloratadine and loratadine stand out among common H1-antihistamines for association with improved breast cancer survival
(
- Contribution to journal › Article
-
Mark
Plasma membrane expression of G protein-coupled estrogen receptor (GPER)/G protein-coupled receptor 30 (GPR30) is associated with worse outcome in metachronous contralateral breast cancer
(
- Contribution to journal › Article
-
Mark
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses
(
- Contribution to journal › Letter
-
Mark
Assessment of interactions between 205 breast cancer susceptibility loci and 13 established risk factors in relation to breast cancer risk, in the Breast Cancer Association Consortium
(
- Contribution to journal › Article
-
Mark
Different domains of self-reported physical activity and risk of type 2 diabetes in a population-based Swedish cohort : the Malmö diet and Cancer study
(
- Contribution to journal › Article
- 2019
-
Mark
A targeted mass spectrometry strategy for developing proteomic biomarkers : a case study of epithelial ovarian cancer
(
- Contribution to journal › Article